InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Income from Continuing Operations came in at 1017000.0 in Q1 2026, up 562.27% YoY from 153562.11 in Q1 2025, and down 50.68% on a QoQ basis from 2062000.0 in Q4 2025.
InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Income from Continuing Operations data on file, last reported at 1017000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 562.27% year-over-year to 1017000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7938000.0 (up 147.29% YoY) and the FY2025 annual result came in at 6627000.0, up 182.6% from the prior year.
- Income from Continuing Operations slipped to 1017000.0 in Q1 2026, from 2062000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 2600000.0 in Q2 2025 to a low of 1098000.0 in Q1 2024.
- A 5-year average of 652235.29 and a median of 443000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 884.38% in 2024, down 266.0% in 2024.
- Tracing INFU's Income from Continuing Operations over 5 years: stood at 138000.0 in 2022, then tumbled by 30.43% to 96000.0 in 2023, then jumped by 884.38% to 945000.0 in 2024, then surged by 118.2% to 2062000.0 in 2025, then sank by 50.68% to 1017000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1017000.0 (Q1 2026), 2062000.0 (Q4 2025), and 2259000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -220,000.00 |
| Dec 31, 2024 | 945,000.00 |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 720,000.00 |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | -300,000.00 |
| Dec 31, 2022 | 138,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | -164,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | 387,000.00 |
| Sep 30, 2021 | -448,000.00 |